methylprednisolone has been researched along with Thalassemias in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhuller, KS; Heran, MK; Rassekh, SR; Wu, JK | 1 |
| Adorno, G; Alfieri, C; Andreani, M; Daniele, N; De Angelis, G; Del Proposto, G; Gallucci, C; Gaziev, J; Isgrò, A; Lanti, A; Lucarelli, G; Marziali, M; Paciaroni, K; Roveda, A; Saltarelli, F; Simone, MD; Sodani, P; Testi, M | 1 |
| Argiolu, F; Bertolino, F; Cornacchia, G; Cossu, P; De Virgiliis, S; Ferreli, A; Nucaro, A; Rais, M; Sanna, G; Toccafondi, C | 1 |
| Argiolu, F; Cao, A; Cornacchia, G; Cossu, P; De Virgiliis, S; Ferreli, A; Nucaro, A; Rais, M; Sanna, G; Toccafondi, C | 1 |
| Jacob, HS; McCullough, J | 1 |
1 trial(s) available for methylprednisolone and Thalassemias
| Article | Year |
|---|---|
Higher CD3(+) and CD34(+) cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Antigens, CD34; Bone Marrow Transplantation; Busulfan; CD3 Complex; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Methylprednisolone; Myeloablative Agonists; Siblings; Thalassemia; Transplantation Conditioning; Transplantation, Homologous | 2012 |
4 other study(ies) available for methylprednisolone and Thalassemias
| Article | Year |
|---|---|
Intra-arterial methylprednisolone for severe steroid refractory gastrointestinal graft-versus-host disease.
Topics: Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Combined Modality Therapy; Drug Resistance; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Infusions, Intra-Arterial; Leukemia, Myeloid, Acute; Methylprednisolone; Prognosis; Steroids; Thalassemia | 2014 |
Methyl-prednisolone treatment of serum HBsAg negative chronic active hepatitis occurring in transfusion-dependent thalassemia major.
Topics: Blood Transfusion; Child; Child, Preschool; Hepatitis B Surface Antigens; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Liver; Methylprednisolone; Thalassemia | 1983 |
Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major.
Topics: Aspartate Aminotransferases; Child; Child, Preschool; Deferoxamine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Hepatitis, Chronic; Humans; Iron; Methylprednisolone; Thalassemia; Transfusion Reaction | 1982 |
The chronically transfused patient: advances in treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Blood Grouping and Crossmatching; Blood Transfusion; Child; Child, Preschool; Cost-Benefit Analysis; Deferoxamine; Erythrocyte Transfusion; Factor VIII; Freeze Drying; Humans; Methylprednisolone; Platelet Transfusion; Thalassemia; Time Factors; Transfusion Reaction; Transplantation Immunology | 1985 |